QA: DICE Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645569_2023_DICE_Therapeutics_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001645569')"}

Graph

Absolute values for 0001645569, DICE Therapeutics Inc.

  xvar xval
0 AssetsCurrent 577,762,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,921,000
3 remainder_Assets 13,295,000
4 LiabilitiesCurrent 15,149,000
5 LiabilitiesNoncurrent 11,841,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,662,000
9 ResearchAndDevelopmentExpense 62,559,000
10 remainder_Expenses 679,000
11 remainder_Revenues 0
12 remainder_NetIncome 5,013,000
13 remainder_ComprehensiveNetIncome -539,000
  yvar yval
0 Assets 593,978,000
1 Liabilities 26,990,000
2 Expenses 88,900,000
3 Revenues 0
4 StockholdersEquity 566,988,000
5 NetIncome -83,887,000
6 ComprehensiveNetIncome -84,156,500
7 BaseVar 357,710,000
8 EconomicCapitalRatio 2.87

Edgar->Model Mapping

Feature Distribution

Change over Time